Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1993 2
1996 2
1997 3
1998 3
1999 1
2000 2
2001 1
2002 3
2003 2
2004 4
2006 1
2009 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

26 results
Results by year
Filters applied: . Clear all
Page 1
Felbamate.
Sachdeo RC. Sachdeo RC. Lancet. 1993 Jul 31;342(8866):300. doi: 10.1016/0140-6736(93)91843-b. Lancet. 1993. PMID: 8101318 No abstract available.
Topiramate. Clinical profile in epilepsy.
Sachdeo RC. Sachdeo RC. Clin Pharmacokinet. 1998 May;34(5):335-46. doi: 10.2165/00003088-199834050-00001. Clin Pharmacokinet. 1998. PMID: 9592618 Review.
Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ Jr, Turk WR, Fischer JH, Bourgeois B, Wilner A, Faught RE Jr, Sachdeo RC, Beydoun A, Glauser TA; Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology; Quality Standards Subcommittee of the American Academy of Neurology; American Epilepsy Society. French JA, et al. Among authors: sachdeo rc. Neurology. 2004 Apr 27;62(8):1252-60. doi: 10.1212/01.wnl.0000123693.82339.fc. Neurology. 2004. PMID: 15111659 Review.
Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society.
French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ Jr, Turk WR, Fischer JH, Bourgeois B, Wilner A, Faught RE Jr, Sachdeo RC, Beydoun A, Glauser TA; American Academy of Neurology Therapeutics and Technology Assessment Subcommittee; American Academy of Neurology Quality Standards Subcommittee; American Epilepsy Society Quality Standards Subcommittee; American Epilepsy Society Therapeutics and Technology Assessment Subcommittee. French JA, et al. Among authors: sachdeo rc. Epilepsia. 2004 May;45(5):401-9. doi: 10.1111/j.0013-9580.2004.06204.x. Epilepsia. 2004. PMID: 15101821 Free article. Review.
Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society.
French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ Jr, Turk WR, Fischer JH, Bourgeois B, Wilner A, Faught RE Jr, Sachdeo RC, Beydoun A, Glauser TA; American Academy of Neurology Therapeutics and Technology Assessment Subcommittee; American Academy of Neurology Quality Standards Subcommittee; American Epilepsy Society Therapeutics and Technology Assessment Subcommittee; American Epilepsy Society Quality Standards Subcommittee. French JA, et al. Among authors: sachdeo rc. Epilepsia. 2004 May;45(5):410-23. doi: 10.1111/j.0013-9580.2004.06304.x. Epilepsia. 2004. PMID: 15101822 Free article. Review.
Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ Jr, Turk WR, Fischer JH, Bourgeois B, Wilner A, Faught RE Jr, Sachdeo RC, Beydoun A, Glauser TA; Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology; Quality Standards Subcommittee of the American Academy of Neurology; American Epilepsy Society. French JA, et al. Among authors: sachdeo rc. Neurology. 2004 Apr 27;62(8):1261-73. doi: 10.1212/01.wnl.0000123695.22623.32. Neurology. 2004. PMID: 15111660 Review.
Topiramate monotherapy for partial onset seizures.
Sachdeo RC, Reife RA, Lim P, Pledger G. Sachdeo RC, et al. Epilepsia. 1997 Mar;38(3):294-300. doi: 10.1111/j.1528-1157.1997.tb01120.x. Epilepsia. 1997. PMID: 9070591 Free article. Clinical Trial.
Caffeinated beverages and decreased seizure control.
Kaufman KR, Sachdeo RC. Kaufman KR, et al. Among authors: sachdeo rc. Seizure. 2003 Oct;12(7):519-21. doi: 10.1016/s1059-1311(03)00048-7. Seizure. 2003. PMID: 12967583 Free article.
Generic versus branded carbamazepine.
Sachdeo RC, Belendiuk G. Sachdeo RC, et al. Lancet. 1987 Jun 20;1(8547):1432. doi: 10.1016/s0140-6736(87)90619-2. Lancet. 1987. PMID: 2884519 No abstract available.
Rapid initiation of gabapentin: a randomized, controlled trial.
Fisher RS, Sachdeo RC, Pellock J, Penovich PE, Magnus L, Bernstein P. Fisher RS, et al. Among authors: sachdeo rc. Neurology. 2001 Mar 27;56(6):743-8. doi: 10.1212/wnl.56.6.743. Neurology. 2001. PMID: 11274308 Clinical Trial.
26 results